Pharmosa Biopharm Inc. (TPEX:6875)

Pharmosa Biopharm Statistics

Total Valuation

TPEX:6875 has a market cap or net worth of TWD 4.69 billion. The enterprise value is 3.93 billion.

Market Cap	4.69B
Enterprise Value	3.93B

Important Dates

The next estimated earnings date is Friday, August 14, 2026.

Earnings Date	Aug 14, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6875 has 129.15 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class	129.15M
Shares Outstanding	129.15M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	-0.13%
Owned by Insiders (%)	9.03%
Owned by Institutions (%)	2.19%
Float	76.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	67.89
PB Ratio	3.20
P/TBV Ratio	3.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.21
EV / Sales	56.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.03

Financial Position

The company has a current ratio of 18.10, with a Debt / Equity ratio of 0.08.

Current Ratio	18.10
Quick Ratio	16.74
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.20
Interest Coverage	-186.29

Financial Efficiency

Return on equity (ROE) is -23.27% and return on invested capital (ROIC) is -13.98%.

Return on Equity (ROE)	-23.27%
Return on Assets (ROA)	-13.39%
Return on Invested Capital (ROIC)	-13.98%
Return on Capital Employed (ROCE)	-25.26%
Weighted Average Cost of Capital (WACC)	5.19%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.04
Inventory Turnover	1.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.60% in the last 52 weeks. The beta is 0.19, so TPEX:6875's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	-19.60%
50-Day Moving Average	37.69
200-Day Moving Average	45.15
Relative Strength Index (RSI)	45.01
Average Volume (20 Days)	198,293

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6875 had revenue of TWD 69.06 million and -385.09 million in losses. Loss per share was -2.98.

Revenue	69.06M
Gross Profit	13.36M
Operating Income	-395.50M
Pretax Income	-385.09M
Net Income	-385.09M
EBITDA	-372.05M
EBIT	-395.50M
Loss Per Share	-2.98

Balance Sheet

The company has 868.42 million in cash and 112.53 million in debt, with a net cash position of 755.89 million or 5.85 per share.

Cash & Cash Equivalents	868.42M
Total Debt	112.53M
Net Cash	755.89M
Net Cash Per Share	5.85
Equity (Book Value)	1.47B
Book Value Per Share	11.36
Working Capital	900.67M

Cash Flow

In the last 12 months, operating cash flow was -402.78 million and capital expenditures -156.30 million, giving a free cash flow of -559.09 million.

Operating Cash Flow	-402.78M
Capital Expenditures	-156.30M
Depreciation & Amortization	23.45M
Net Borrowing	-18.68M
Free Cash Flow	-559.09M
FCF Per Share	-4.33

Margins

Gross Margin	19.35%
Operating Margin	-572.69%
Pretax Margin	-557.61%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6875 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.02%
Shareholder Yield	-0.02%
Earnings Yield	-8.21%
FCF Yield	-11.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1